Fundraising FoxIllumina Innovation — Full Portfolio
5 tracked investments · listed companies and verified rows first
Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.
BiotechDigital HealthHealthtechSouth San Francisco, US
Lisa Alderson(Executive Officer, Director)inRandal Scott(Director)Jill Davies(Executive Officer, Director)inElizabeth Moreno(Executive Officer)inMark Sylvester(Chief Financial Officer)inAndrew Warner(Vice President, Product)in
Board seatNicholas Naclerio· per SEC Form D · $15M raise · filed Jul 2020
Co-investorsAlumni VenturesAvestria VenturesCanaan PartnersDreamers VCEcho Health VenturesGV (Google Ventures)+11 more
Pattern develops rapid antibiotic susceptibility and infection diagnostics using single-cell microbiology, which reads the metabolic patterns of individual bacterial cells to deliver ID/AST results in hours without culture steps.
BiotechHealthtechMedical DevicesAustin, US
Nick Arab(Founder & CTO)Ross Johnson(Co-founder & Chief Engineer)inCarey-Ann Burnham(Chief Executive Officer)inTravis Davies(SVP, Operations)inKyle Fieleke(SVP, Corporate Development & Finance)inDavid Bussian(SVP, Clinical, Regulatory & Assay Development)in
Board seatNicholas Naclerio· per SEC Form D · $61.2M raise · filed Aug 2025
Co-investorsAMR Action FundIllumina Ventures
BiotechGoleta, US
Patrick Daugherty(Executive Officer, Director)Kristin Loomis(Director)Bill Welch(Director)inNick Naclerio(Director)inJohn Shon(Executive Officer)
Board seatNicholas Naclerio· per SEC Form D · $16.5M raise · filed Nov 2023
Co-investorsIllumina Ventures
Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale.
BiotechDeep TechMedical DevicesCambridge, GB
Co-investorsARCH Venture PartnersIllumina VenturesPerscitus LLP+ND CapitalM VenturesOMX Ventures
Tagomics develops multimodal technologies for precision medicine and next-generation diagnostics.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, GB
Dr Jack Kennefick(Co-founder, Director & Chief Executive Officer)Dr Robert Neely(Co-founder, Director & Chief Scientific Officer)
Co-investorsCalculus Capital Ltd.Illumina VenturesIQ CapitalCalculusInnovate UKMEIF Proof-of-Concept & Early Stage Fund+3 more
.jpeg){kind=logo}
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.